132.03
price down icon3.52%   -4.81
after-market Handel nachbörslich: 132.50 0.47 +0.36%
loading

Biogen Inc Aktie (BIIB) Neueste Nachrichten

pulisher
04:30 AM

Biogen Inc. stock outperforms competitors despite losses on the day - MarketWatch

04:30 AM
pulisher
04:06 AM

Multiple Sclerosis Pipeline 2025: Key Companies, MOA, ROA, - openPR.com

04:06 AM
pulisher
09:03 AM

FDA-Approved Biosimilars Market: A Complete List & Latest - openPR.com

09:03 AM
pulisher
08:29 AM

Organon buys rights to Biogen’s Actemra biosimilar (OGN:NYSE) - Seeking Alpha

08:29 AM
pulisher
08:02 AM

Organon acquires US rights to arthritis biosimilar TOFIDENCE - Investing.com India

08:02 AM
pulisher
07:56 AM

Organon acquires US rights to arthritis biosimilar TOFIDENCE By Investing.com - Investing.com Australia

07:56 AM
pulisher
07:30 AM

Organon Claims US Market Leadership with Groundbreaking Tocilizumab Biosimilar Deal - Stock Titan

07:30 AM
pulisher
06:58 AM

EC refers lecanemab decision to Appeal Committee - The Pharma Letter

06:58 AM
pulisher
06:23 AM

Saratoga Research & Investment Management Reduces Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

06:23 AM
pulisher
06:12 AM

Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years - Yahoo Finance

06:12 AM
pulisher
06:03 AM

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission - Biogen

06:03 AM
pulisher
04:51 AM

Biogen Inc. (NASDAQ:BIIB) Shares Sold by DnB Asset Management AS - MarketBeat

04:51 AM
pulisher
04:45 AM

Pictet Asset Management Holding SA Trims Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

04:45 AM
pulisher
Mar 31, 2025

Thrivent Financial for Lutherans Has $2.42 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

The US Approved an Alzheimer's Drug. Seven Patients Subsequently Died - Bloomberg.com

Mar 31, 2025
pulisher
Mar 31, 2025

The US approved an Alzheimer’s drug. Seven patients subsequently died. - The Boston Globe

Mar 31, 2025
pulisher
Mar 31, 2025

United Bank Sells 2,213 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Level Four Advisory Services LLC Has $1.14 Million Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Norges Bank Purchases New Shares in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Mitsubishi UFJ Trust & Banking Corp Increases Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

UniSuper Management Pty Ltd Sells 42,345 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Elo Mutual Pension Insurance Co Raises Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 31, 2025
pulisher
Mar 31, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat

Mar 31, 2025
pulisher
Mar 30, 2025

Biogen CEO Looks for Small Deals While Alzheimer’s Drug Ramps Up - MSN

Mar 30, 2025
pulisher
Mar 30, 2025

Biogen (NASDAQ:BIIB) Shares Acquired Rep. Robert Bresnahan, Jr. - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Beutel Goodman & Co Ltd. Raises Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Acquired by NEOS Investment Management LLC - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Vanguard Group Inc. Buys 70,368 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 30, 2025
pulisher
Mar 29, 2025

Virtu Financial LLC Decreases Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

Prudential Financial Inc. Acquires 152,992 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 29, 2025
pulisher
Mar 29, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Sold by HighTower Advisors LLC - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

Eli Lilly Alzheimer’s Drug Kisunla Fails to Get EU Backing - Mint

Mar 28, 2025
pulisher
Mar 28, 2025

European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For BiogenEli Lilly (NYSE:LLY) - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

Lilly hits same Alzheimer’s roadblock in Europe as Eisai, Biogen - BioPharma Dive

Mar 28, 2025
pulisher
Mar 28, 2025

Trend Tracker for (BIIB) - Stock Traders Daily

Mar 28, 2025
pulisher
Mar 28, 2025

Mizuho Securities USA LLC Raises Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Acquired by Teacher Retirement System of Texas - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Natixis Advisors LLC Reduces Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Hillsdale Investment Management Inc. Buys Shares of 4,610 Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Biogen Inc. (NASDAQ:BIIB) Stock Holdings Trimmed by Northwest & Ethical Investments L.P. - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

BIIB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 27, 2025

Biogen: Balancing Risks And Opportunities - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

Biogen plans new headquarters at Kendall Common - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025 - The Motley Fool

Mar 27, 2025
pulisher
Mar 27, 2025

Lilly adds Alzheimer's to online offerings - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

6,175 Shares in Biogen Inc. (NASDAQ:BIIB) Acquired by Crowley Wealth Management Inc. - MarketBeat

Mar 27, 2025
pulisher
Mar 27, 2025

Biogen to Move Global Headquarters to Kendall Commons in 2028 - The Harvard Crimson

Mar 27, 2025
pulisher
Mar 26, 2025

1,874 Shares in Biogen Inc. (NASDAQ:BIIB) Purchased by Vinva Investment Management Ltd - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

Sector Gamma AS Sells 6,166 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 25, 2025
pulisher
Mar 25, 2025

BIOGEN TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS MAY 1, 2025 - Biogen

Mar 25, 2025
pulisher
Mar 25, 2025

Roche Voids Biogen's Protein Production Patent At EPO - Law360

Mar 25, 2025
pulisher
Mar 25, 2025

Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your RightsBIIB - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square - Boston Real Estate Times

Mar 25, 2025
pulisher
Mar 25, 2025

Cassava Sciences shuts down Alzheimer's programshares plummet - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

KLP Kapitalforvaltning AS Acquires Shares of 92,377 Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

News | Blackstone’s BioMed adds biotech hub in Boston area with added demand - CoStar Group

Mar 24, 2025
pulisher
Mar 24, 2025

7 Stocks Still Trading Below COVID Lows 5 Years Later - MSN

Mar 24, 2025
pulisher
Mar 24, 2025

Biogen to Relocate Headquarters to New Development by MIT and BioMed - Connect CRE

Mar 24, 2025
drug_manufacturers_general SNY
$54.34
price down icon 2.02%
$111.28
price down icon 0.69%
drug_manufacturers_general PFE
$24.54
price down icon 3.16%
$306.92
price down icon 1.49%
drug_manufacturers_general NVS
$109.61
price down icon 1.68%
drug_manufacturers_general MRK
$87.12
price down icon 2.94%
Kapitalisierung:     |  Volumen (24h):